NCT07193563 - A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder | Biotech Hunter

Enrollment

220

Participants

Timeline

Start Date

September 5, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions

Social Anxiety Disorder (SAD)

Interventions

DRUG

ENX-102

oral capsule

OTHER

Placebo

oral capsule

Trial Locations (16)

11516

RECRUITING

Neurobehavioral Research, Inc., Cedarhurst

31405

RECRUITING

CenExel iResearch, LLC, Savannah

32256

RECRUITING

CNS Health, Jacksonville

32801

RECRUITING

Clinical Neuroscience Solutions, Inc., Orlando

38119

RECRUITING

Clinical Neurosciences, Inc, Memphis

76309

RECRUITING

Grayline Research Center, Wichita Falls

78737

RECRUITING

Austin Clinical Trials Partners, Austin

80209

RECRUITING

Mountain View Clinical Research, Denver

85012

RECRUITING

IMA Clinical Research Phoenix, Phoenix

89119

RECRUITING

Redbird Research, Las Vegas

90025

RECRUITING

Neuroresearch Group, Los Angeles

91403

RECRUITING

California Neuroscience Research, LLC, Sherman Oaks

92056

RECRUITING

Excell Research, Inc., Oceanside

92374

RECRUITING

Anderson Clinical Research, Redlands

94596

RECRUITING

Sunwise Clincial Research, Walnut Creek

08009

RECRUITING

Cenexel HRI, Berlin